Rafael D. R. V.
- Country
- Spain
- Department
- Neurophysiology
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
- A Randomized, Double‑Blind, Placebo‑Controlled Study of TAK‑360 for Safety, Tolerability, and Efficacy in Adults with Narcolepsy Type 1 (Cataplexy)
Data & Insights
Has run more than one trial at 48 of 61 partner sites.
Specializations
Sleep Disorders Research
This investigator specializes in studying various forms of sleep disorders, with particular emphasis on narcolepsy and its subtypes.
- Narcolepsy Type 1 with Cataplexy
- Narcolepsy Type 2
- Idiopathic Hypersomnia
The research focuses on evaluating novel therapeutic approaches for these conditions.
Treatment Development
The investigator conducts research on innovative treatments including TAK-861, TAK-360, and ALKS 2680 for sleep-wake disorders.
- Safety Assessment Studies
- Long-term Tolerability Evaluation
- Treatment Efficacy Analysis
Research encompasses both short-term and long-term therapeutic outcomes.
Clinical Assessment
Expertise in evaluating excessive daytime sleepiness and related symptoms using standardized measurements.
- Epworth Sleepiness Scale Assessment
- Safety Profile Analysis
- Treatment Response Monitoring
Focuses on comprehensive evaluation of treatment outcomes in sleep disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.